title: Stereotactic boost irradiation for targets in the abdomen and pelvis.
abstract: Based on the experience of stereotactic irradiation of lung and liver tumors the feasibility of stereotactic boost irradiation to abdominal and pelvic tumors was evaluated. Twenty-one patients with inoperable tumors received a stereotactic boost of 2-3 x 5Gy/PTV-enclosing-100% isodose with normalization to 150% at the isocenter after normofractionated irradiation of 45-50.4Gy. Actuarial local control (16/21 targets) was 96/70% after 12 and 24 months. Treatment was feasible and well tolerated.
authors.affiliation: Department of Radiotherapy, University of Würzburg, Josef-Schneider-Strasse 11, D-97080 Würzburg, Germany.
authors.forename: Jörn
authors.initials: J
authors.lastname: Wulf
authors.forename: Ulrich
authors.initials: U
authors.lastname: Hädinger
authors.forename: Ulrich
authors.initials: U
authors.lastname: Oppitz
authors.forename: Wibke
authors.initials: W
authors.lastname: Thiele
authors.forename: Michael
authors.initials: M
authors.lastname: Flentje
mesh_terms: D000008:Abdominal Neoplasms / Q000532:radiotherapy*; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy*; D010386:Pelvic Neoplasms / Q000532:radiotherapy*; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods*; D013238:Stereotaxic Techniques; D016896:Treatment Outcome